Skip to Main Content

Paper Details

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol
138
2022
Cancer, HER2, RCB, breast cancer, cancer, participant, patient, patients, tumour
Author NameAffiliation
Christina YauUniversity of California san francisco
Christina YauUniversity of California san francisco
Judy C BougheyMayo Clinic
Matthew P GoetzMayo Clinic
Tanya L HoskinMayo Clinic
John M S BartlettOntario Institute for Cancer Research, Edinburgh Cancer Research Centre, University of Toronto
Carlos CaldasUniversity of Cambridge
Janet A DunnWarwick Clinical Trials Unit, University of Warwick
Stephen-John SammutUniversity of Cambridge
Lajos PusztaiYale University
Mi-Ok KimUniversity of California san francisco
Laura J Van't VeerUniversity of California san francisco
William F SymmansThe University of Texas MD Anderson Cancer Center
  • 1 - 13

Datasets

Release 1.2